Wednesday, June 4, 2014 at 1:30 PM PDT on Track One The Luxe Sunset Bel Air, Los Angeles, California
Fairfield, Conn. - (June 2, 2014) - Competitive Technologies, Inc., (CTTC) (CTI), the pain mitigation company, will present at LD MICRO's 4th Invitational Conference on Wednesday, June 4, 2014, at 1:30 PM PDT / 4:30 PM EDT.
The event will host 100 companies in the micro-cap space at the Luxe Sunset Bel Air in Los Angeles, California. "We are honored to have Competitive Technologies present at the conference," stated Chris Lahiji, President of LD MICRO.
CTI President & CEO Conrad Mir will present and discuss the Company's corporate business plan and provide an update on CTI's corporate reengineering initiative. He will be available for one-on-one meetings during the conference.
About LD MICRO
LD MICRO is a by-invitation-only, newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks, as well as comprehensive reports on select companies throughout the year. The firm also hosts the LD MICRO Micro-Cap Growth Conference for investors in December of each year. LD MICRO concentrates on finding, researching and investing in companies that are overlooked by most institutional investors. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com.
About the Company
Competitive Technologies Inc., the pain mitigation company, develops and commercializes innovative wound and pain management products and technologies. CTI holds the 510k clearance on its flagship product, the non-invasive Calmare® Pain Therapy Device, which grants it an exclusive right to sell, market, research and develop the medical device. The Company is the exclusive licensed global distributor of Calmare.
Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations and statements of future economic performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to differ materially from what is currently anticipated. Factors that could cause or contribute to such differences include those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission. The Company cannot guarantee its future results, levels of activity, performance or achievements.